Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Exploring neuroanatomy and neuropsychology in digital financial decision-making: betrayal aversion and risk behavior.
Brain Imaging Behav
January 2025
Faculty of Economics and Business, University of Granada, Campus Universitario de Cartuja, Granada, CP, 18071, Spain.
Detecting the factors associated with financial decision-making is an unresolved challenge when trying to predict digital financial behavior. This paper reports experimental results on both neuropsychological and neuronal correlates of risk-taking and betrayal aversion among 121 healthy participants (X=21.7; SD = 2.
View Article and Find Full Text PDFDo Novel Nonexercise and Nondrug Treatments Improve Global Cognition in Parkinson's Disease Patients? A Systematic Review and Bayesian Analysis.
Eur J Neurosci
February 2025
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
This Bayesian network meta-analysis method was used to assess the effect of novel treatments on global cognition in patients with Parkinson's disease (PD). We searched randomized controlled trials from PubMed, Cochrane Library, Web of Science and Embase to investigate novel treatments for global PD cognition until April 10, 2024. Effect size measures were standardized mean differences with 95% confidence intervals.
View Article and Find Full Text PDFBiomarker treatment effects in two phase 3 trials of gantenerumab.
Alzheimers Dement
January 2025
Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
Introduction: We report biomarker treatment effects in the GRADUATE I and II phase 3 studies of gantenerumab in early Alzheimer's disease (AD).
Methods: Amyloid and tau positron emission tomography (PET), volumetric magnetic resonance imaging (vMRI), cerebrospinal fluid (CSF), and plasma biomarkers used to assess gantenerumab treatment related changes on neuropathology, neurodegeneration, and neuroinflammation over 116 weeks.
Results: Gantenerumab reduced amyloid PET load, CSF biomarkers of amyloid beta (Aβ)40, total tau (t-tau), phosphorylated tau 181 (p-tau181), neurogranin, S100 calcium-binding protein B (S100B), neurofilament light (NfL), alpha-synuclein (α-syn), neuronal pentraxin-2 (NPTX2), and plasma biomarkers of t-tau, p-tau181, p-tau217, and glial fibrillary acidic protein (GFAP) while increasing plasma Aβ40, Aβ42.
[Evaluation of the efficiency of combined pharmaco-physiotherapy in patients with dry eye syndrome].
Vopr Kurortol Fizioter Lech Fiz Kult
January 2025
Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Objective: To evaluate the effectiveness of a treatment complex including magnetophoresis with the drug «Argensept» and tear therapy in patients with mild to moderate dry eye syndrome.
Material And Methods: The study was conducted on 50 people (100 eyes) diagnosed with mild to moderate dry eye syndrome (H04.1 according to ICD-10).
[Efficiency of dry salt baths and magnetic-laser exposure in the rehabilitation treatment of patients with chronic prostatitis].
Vopr Kurortol Fizioter Lech Fiz Kult
January 2025
Bashkir State Medical University, Ufa, Russia.
Objective: To evaluate the efficiency of treatment complexes based on magnetic-laser therapy with electrical stimulation and dry salt baths in the rehabilitation treatment of patients with chronic prostatitis.
Material And Methods: There have been observed 74 men with chronic abacterial prostatitis at the age of 34-46 years old. The patients were divided into groups using the simple randomization method depending on the therapy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!